Pravastatin

Brand names: PRAVACHOL, PRAVASTATIN SODIUM, Pravastatin Sodium, Pravastatin sodium, pravastatin sodium

Warnings

No boxed warning. Contraindications include "hypersensitivity to any component of this medication," "active liver disease or unexplained, persistent elevations of serum transaminases," and use during pregnancy and lactation. Key warnings cover skeletal muscle effects - patients should report "unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever" - with rare cases of "rhabdomyolysis with acute renal failure secondary to myoglobinuria," and rare immune-mediated necrotizing myopathy (IMNM) with "proximal muscle weakness and elevated serum creatine kinase, which persist despite discontinuation of statin treatment."

Uses

Pravastatin is indicated to reduce the risk of MI, revascularization, and cardiovascular mortality in hypercholesterolemic patients without clinically evident coronary heart disease, and in patients with existing coronary heart disease to reduce "the risk of total mortality by reducing coronary death, MI, revascularization, stroke/TIA, and the progression of coronary atherosclerosis." Also indicated as an adjunct to diet for elevated total cholesterol, LDL-C, and triglycerides, and for "heterozygous familial hypercholesterolemia" in pediatric patients 8 years and older who fail diet therapy.

Dosage forms & strengths

Tablet
PRAVASTATIN SODIUM 10 mg PRAVASTATIN SODIUM 20 mg PRAVASTATIN SODIUM 40 mg PRAVASTATIN SODIUM 80 mg Pravastatin Sodium 10 mg Pravastatin Sodium 20 mg Pravastatin Sodium 40 mg Pravastatin Sodium 80 mg pravastatin sodium 10 mg pravastatin sodium 20 mg pravastatin sodium 40 mg pravastatin sodium 80 mg

All identified pills

Side effects

In short-term trials, the most frequent reactions were "musculoskeletal pain, nausea/vomiting, upper respiratory infection, diarrhea, and headache." Long-term data reported musculoskeletal pain in 24.9% of patients, fatigue in 8.4%, and upper respiratory tract infection in 21.2%. Postmarketing reports include myopathy, rhabdomyolysis, tendon disorder, polymyositis, and rare cognitive impairment ("memory loss, forgetfulness, amnesia, memory impairment, confusion").

Official source

DailyMed